Alivus Life Sciences Limited

rs,

ctober 21, 2022 To, Dy. General Manager Department of Corporate Services, BSE Ltd., P. J. Towers, Dalal Street, Fort, Mumbai – 400 001 Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (E),

13%

th on a sequential basis. External businesses (ex-GPL) was the key driver for this quarter, growing 13% YoY India, LATAM, and Japan basis and 16% QoQ. drove the growth during the quarter. The CDMO busine

16%

ses (ex-GPL) was the key driver for this quarter, growing 13% YoY India, LATAM, and Japan basis and 16% QoQ. drove the growth during the quarter. The CDMO business picked up during the quarter, posting 2

27%

% QoQ. drove the growth during the quarter. The CDMO business picked up during the quarter, posting 27% growth QoQ. I am happy to announce that we have completed the Dahej Capex and commenced commercial

INR 5,093

steadily in coming quarters with our differentiated products and wide geographical reach.” Revenue INR 5,093 mn l YoY, -9.3% t QoQ, 4% • Revenue grew by 4% on a QoQ and decreased 4% over a higher base

9.3%

ers with our differentiated products and wide geographical reach.” Revenue INR 5,093 mn l YoY, -9.3% t QoQ, 4% • Revenue grew by 4% on a QoQ and decreased 4% over a higher base of Q2FY22 (ex-covi

4%

fferentiated products and wide geographical reach.” Revenue INR 5,093 mn l YoY, -9.3% t QoQ, 4% • Revenue grew by 4% on a QoQ and decreased 4% over a higher base of Q2FY22 (ex-covid) • Gross M

52.9%

rew by 4% on a QoQ and decreased 4% over a higher base of Q2FY22 (ex-covid) • Gross Margins are at 52.9%, up 120 bps YoY driven by a better product mix and PLI scheme benefit • EBITDA margins remain ste

120 bps

on a QoQ and decreased 4% over a higher base of Q2FY22 (ex-covid) • Gross Margins are at 52.9%, up 120 bps YoY driven by a better product mix and PLI scheme benefit • EBITDA margins remain steady at 30.2%

30.2%

0 bps YoY driven by a better product mix and PLI scheme benefit • EBITDA margins remain steady at 30.2% in Q2, with a slight sequential decline due to higher utility and employee cost / EBITDA INR 1,5

INR 1,537

t 30.2% in Q2, with a slight sequential decline due to higher utility and employee cost / EBITDA INR 1,537 mn PAT INR 1,069 mn • Generic API capex at Dahej is completed with 240KL capacity coming online f

INR 1,069

h a slight sequential decline due to higher utility and employee cost / EBITDA INR 1,537 mn PAT INR 1,069 mn • Generic API capex at Dahej is completed with 240KL capacity coming online from Q3 FY23, incre